Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Fixed Capital/Sales

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023
   Fixed Capital/Sales(x) 2.010.61

What is the latest Fixed Capital/Sales ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Fixed Capital/Sales ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 2.01 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20242.01
Mar20230.61

How is Fixed Capital/Sales of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Fixed Capital/Sales % Change
Mar2024 2.01
229.51
Mar2023 0.61 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Fixed Capital/Sales ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹4,711.7 Cr -1.9% 14.8% -60.8% Stock Analytics
SYNGENE INTERNATIONAL ₹29,188.0 Cr -0.1% 10.8% 3.5% Stock Analytics
SAGILITY INDIA ₹18,968.7 Cr -5.7% -4.9% NA Stock Analytics
LATENT VIEW ANALYTICS ₹7,516.6 Cr -0.9% -2.7% -29.8% Stock Analytics
JUST DIAL ₹6,991.3 Cr 0.9% -0.1% -3.1% Stock Analytics
AWFIS SPACE SOLUTIONS ₹4,568.2 Cr -2.8% -1.9% NA Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-1.9%

14.8%

-60.8%

SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses